John is a senior sell side analyst at Bell Potter Securities in Sydney . He specialise in small and mid cap healthcare stocks, however, has also followed a wide variety of stocks over 10 years in the securities industry. These range from small biotechs to very large multinationals.. His deep know knowledge of complex stocks including Mayne Pharma, Medibank Private, Sirtex Medical and Viralytics have earned wide recognition from clients during course of 2015 and 2016. In addition to the fundamentals around capital structure and balance sheet strength, he looks for one or more of the following characteristics in a stock: Normally the CEO has had an integral part in establishing the company or providing outstanding vision. Scott Richards at Mayne Pharma and George Saviddes (former CEO of MPL) are good examples. "I take a great deal of confidence from a CEO who has grown with the company and is clever enough to surround himself with an experienced team". Secondly, if it is a technology or biotech stock, the science has to stack up. "I generally steer clear of stocks where there is an absence of solid evidence from clinical trial data. This rules out a lot of start ups and early stage c
ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.
